Daily Archives: June 4, 2012

Everist Genomics Announces Publication of Validation Study Confirming OncoDefender-CRC Independently Predicts Recurrence Risk for Early Stage Colorectal Cancer Patients

Posted on June 4, 2012 by admin

- Findings Published in CANCER Support Clinical Use of OncoDefender-CRC for Personalizing Treatment Planning for CRC Patients – Ann Arbor, Michigan June 4, 2012 – Everist Genomics, a rapidly growing personalized medicine company, today announced the publication of positive results … Continue reading →

Posted in press releases | Leave a comment